REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Synthon, S.R.O. (Czech Republic)

Main Activities: Medicinal and Botanical Manufacturing | Pharmaceutical Preparation Manufacturing
Secondary Activities: Other Basic Organic Chemical Manufacturing | Other Chemical and Allied Products Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Research and Development in Nanotechnology
Full name: Synthon, S.R.O. Profile Updated: April 18, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Synthon, S.R.O. is based in Czech Republic. The head office is in Blansko. It operates in the Medicinal and Botanical Manufacturing sector. It was incorporated on February 28, 2000. 250 - 499 (2025) employees currently work for Synthon, S.R.O.. From the latest financial highlights, Synthon, S.R.O. reported a net sales revenue drop of 5.73% in 2024. A negative growth of 5.94% was recorded in its total assets. The enterprise’s net profit margin increased by 1.79% in 2024.

Headquarters
Brnenska 597/32
Blansko; Jihomoravsky; Postal Code: 67801

Contact Details: Purchase the Synthon, S.R.O. report to view the information.

Website: http://www.synthon.com

Basic Information
Total Employees:
Purchase the Synthon, S.R.O. report to view the information.
Registered Capital:
Purchase the Synthon, S.R.O. report to view the information.
Financial Auditors:
Purchase the Synthon, S.R.O. report to view the information.
Incorporation Date:
February 28, 2000
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
CHEMIE BRNO, spol. s r.o.
80%
Company Performance
Financial values in the chart are available after Synthon, S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
-5.73%▼
Total Operating Revenue
-4.86%▼
Operating Profit
12.59%▲
EBITDA
11.03%▲
Net Profit/Loss for the Period
13.75%▲
Total Assets
-5.94%▼
Total Equity
-4.89%▼
Operating Profit Margin
1.63%▲
Net Profit Margin
1.79%▲
Return on Equity (ROE)
1.38%▲
Quick Ratio
-0.03%▼
Cash Ratio
0.01%▲

Similar companies

Vuab Pharma A.S.
 
Cayman Pharma S.R.O.
Immunotech S.R.O.
 
Agel Transfuzni Sluzba A.S.
Mb Pharma S.R.O.
 
Fagofarma S.R.O.

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo